These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 215990)

  • 21. Vasoactive intestinal polypeptide secreting islet cell tumors: a 15-year experience and review of the literature.
    Smith SL; Branton SA; Avino AJ; Martin JK; Klingler PJ; Thompson GB; Grant CS; van Heerden JA
    Surgery; 1998 Dec; 124(6):1050-5. PubMed ID: 9854582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of a pancreatic tumor containing vasoactive intestinal peptide, neurotensin, and pancreatic polypeptide.
    Shulkes A; Boden R; Cook I; Gallagher N; Furness JB
    J Clin Endocrinol Metab; 1984 Jan; 58(1):41-8. PubMed ID: 6315763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasoactive intestinal polypeptide and gastrin-producing islet cell carcinoma.
    Judge DM; Demers LM; Nahrwold DL; Dickman PS; Petrokubi RJ; Trapukdi S
    Arch Pathol Lab Med; 1977 May; 101(5):262-5. PubMed ID: 192171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. WDHA syndrome caused by VIP-producing ganglioneuroblastoma.
    Kudo K; Kitajima S; Munakata H; Yagihashi S
    J Pediatr Surg; 1982 Aug; 17(4):426-8. PubMed ID: 6288909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carcinoid APUDoma of the pancreas.
    Cholankeril JV; McHugh WJ; Ketyer S; Giardina AC
    Cardiovasc Intervent Radiol; 1981; 4(1):51-5. PubMed ID: 7018687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasoactive intestinal peptide (VIP) secreting tumour of the pancreas.
    Sandström R; Alhava EM; Poikolainen E; Puittinen J; Soimakallio S
    Ann Chir Gynaecol; 1981; 70(3):124-7. PubMed ID: 6275768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secretin, cholecystokinin, and vasoactive intestinal polypeptide in pancreatic cholera.
    Achord JL
    Ann Intern Med; 1986 Oct; 105(4):632. PubMed ID: 3019205
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hormones of the digestive system. II. Pathology].
    Vigouroux N; Thomas M
    Med Chir Dig; 1978; 7(4):289-302. PubMed ID: 209259
    [No Abstract]   [Full Text] [Related]  

  • 29. [VIP and GIP-producing pancreatic tumour: relationship to the Verner-Morrison syndrome].
    Kunert H; Kuhn FM; Schwemmle K; Ottenjann R
    Dtsch Med Wochenschr; 1976 Jun; 101(24):920-3. PubMed ID: 179772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of pancreatic polypeptide and vasoactive intestinal polypeptide on rat ileal and colonic water and electrolyte transport in vivo.
    Wu ZC; O'Dorisio TM; Cataland S; Mekhjian HS; Gaginella TS
    Dig Dis Sci; 1979 Aug; 24(8):625-30. PubMed ID: 223821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diarrheic syndrome and beta cell tumors of the pancreas: the Verner-Morrison syndrome: report of a case].
    Machado MC; Bettarello A; Mott CB; Bacchella T; da Cunha JE
    Rev Hosp Clin Fac Med Sao Paulo; 1981 Apr; 36(2):78-85. PubMed ID: 6275483
    [No Abstract]   [Full Text] [Related]  

  • 32. Hormone producing pancreatic islet cell carcinoma: changing clinical presentation.
    Broor SL; Soergel KH; Garancis JC; Wilson SD
    Am J Med Sci; 1979; 278(3):229-33. PubMed ID: 231906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resolution of recurrent Verner-Morrison syndrome by resection of metastatic vipoma.
    Nagorney DM; Bloom SR; Polak JM; Blumgart LH
    Surgery; 1983 Feb; 93(2):348-53. PubMed ID: 6297109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vasoactive intestinal polypeptide (VIP) as a mediator of the watery diarrhea syndrome.
    Said SI
    World J Surg; 1979 Sep; 3(5):559-63. PubMed ID: 229653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for secretion of vasoactive intestinal peptide by tumours of pancreas, adrenal medulla, thyroid and lung: support for the unifying APUD concept.
    Said SI
    Clin Endocrinol (Oxf); 1976; 5 Suppl():201S-204S. PubMed ID: 29733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Vipomas].
    Dupont C
    Ann Med Interne (Paris); 1984; 135(5):400-2. PubMed ID: 6091517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Large cell carcinoma with calcitonin and vasoactive intestinal polypeptide-associated Verner-Morrison syndrome.
    Pratz KW; Ma C; Aubry MC; Vrtiska TJ; Erlichman C
    Mayo Clin Proc; 2005 Jan; 80(1):116-20. PubMed ID: 15667039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vasoactive intestinal peptide in man: pharmacokinetics, metabolic and circulatory effects.
    Domschke S; Domschke W; Bloom SR; Mitznegg P; Mitchell SJ; Lux G; Strunz U
    Gut; 1978 Nov; 19(11):1049-53. PubMed ID: 730072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Verner-Morrison syndrome (1 case with determination of vasoactive intestinal peptide (V.I.P.) and electron microscope study)].
    Lescut J; Mazzuca M; Hanon D; Ribet M
    Lille Med; 1979 Mar; 24(3):189-93. PubMed ID: 226822
    [No Abstract]   [Full Text] [Related]  

  • 40. [Endocrinologic studies of tumors of Langerhans Islands].
    Yamaguchi K; Abe K
    Nihon Rinsho; 1980; 38(1):30-8. PubMed ID: 6248656
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.